Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary

Autologous stem cell transplantation (ASCT) is the standard treatment of primary refractory or relapsed Hodgkin-lymphoma, which can provide a cure rate of about 50%. The aim of our study was to analyze the data of 126 HL patients undergoing AHSCT in Hungary between 01/01/2016 and 31/12/2020. We asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Husi, Kata, Szabó, Roxána, Pinczés, László Imre, Földeák, Dóra, Dudley, Réka, Szomor, Árpád, Koller, Beáta, Gopcsa, László, Illés, Árpád, Miltényi, Zsófia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444678/
https://www.ncbi.nlm.nih.gov/pubmed/37428200
http://dx.doi.org/10.1007/s00277-023-05354-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444678/
https://www.ncbi.nlm.nih.gov/pubmed/37428200
http://dx.doi.org/10.1007/s00277-023-05354-8

Ejemplares similares